-
Mashup Score: 0
RBBB remains the single strongest predictor for PPMI after TAVR, but high AV calcium scores still provide care teams with considerable value.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say - 4 day(s) ago
The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Diabetes reduces survival after SAVR, but not TAVR - 4 day(s) ago
“TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR,” researchers wrote. “This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications.”
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2FDA regulator examines AI's growing influence in cardiology - 4 day(s) ago
Stephen Browning, the FDA’s assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency’s perspective on AI-enabled cardiovascular devices and many other topics.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported - 5 day(s) ago
Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
Cardiologists shared updated data on Medtronic’s ICM and PFA offerings during AF Symposium 2025 in Boston.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
Rebecca Hahn, MD, discussed key takeaways from the TRISCEND II trial for the Edwards Lifesciences Evoque TTVR valve and shared additional details related to patient selection and implanting the device.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1New research highlights rising interest in LBBAP - 7 day(s) ago
The first patient has been enrolled in a new study of an optimized lead for LBBAP, an area with an explosion of interest in EP as a way to improve patient outcomes.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Black, rural and low-income PAD patients are less likely to receive high-quality care - 8 day(s) ago
“This research should be a call to health systems, policymakers and other stakeholders to make it easier for patients—especially the most vulnerable patients—to access PAD-specific care,” one cardiologist explained.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
An advanced algorithm was trained to evaluate more than 100 different details about the inside of a patient’s eye. Its ability to identify high-risk patients was comparable to more traditional techniques, exciting researchers.
Source: cardiovascularbusiness.comCategories: General Medicine News, CardiologistsTweet
Aortic valve calcium scores predict when #TAVR patients may need a permanent pacemaker #cardiology https://t.co/MpZt6zFcsr